Yuxuan Li

908 total citations · 1 hit paper
31 papers, 697 citations indexed

About

Yuxuan Li is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Yuxuan Li has authored 31 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 6 papers in Cancer Research and 6 papers in Biomedical Engineering. Recurrent topics in Yuxuan Li's work include CRISPR and Genetic Engineering (6 papers), RNA and protein synthesis mechanisms (4 papers) and RNA Research and Splicing (4 papers). Yuxuan Li is often cited by papers focused on CRISPR and Genetic Engineering (6 papers), RNA and protein synthesis mechanisms (4 papers) and RNA Research and Splicing (4 papers). Yuxuan Li collaborates with scholars based in China, Belgium and South Korea. Yuxuan Li's co-authors include Hexiang Gong, Yanli Li, Ruijin Zeng, Wei Lin, Dietmar Knopp, Dianping Tang, Tao Liu, Yangming Wang, Tingting Li and Shulang Chen and has published in prestigious journals such as Nucleic Acids Research, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Yuxuan Li

28 papers receiving 689 citations

Hit Papers

CRISPR-Cas12a-Derived Photoelectrochemical Biosensor for ... 2022 2026 2023 2024 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuxuan Li China 12 528 234 97 81 40 31 697
Yi Jia China 17 502 1.0× 280 1.2× 80 0.8× 45 0.6× 86 2.1× 37 853
Anna S. Zamay Russia 17 544 1.0× 344 1.5× 49 0.5× 69 0.9× 31 0.8× 32 738
Yue Xu China 12 336 0.6× 63 0.3× 89 0.9× 82 1.0× 40 1.0× 34 595
David S. Roberts United States 17 554 1.0× 133 0.6× 64 0.7× 24 0.3× 20 0.5× 36 911
Xiyu Liu China 14 230 0.4× 212 0.9× 98 1.0× 29 0.4× 30 0.8× 41 532
Rémi Le Borgne France 14 277 0.5× 168 0.7× 104 1.1× 31 0.4× 19 0.5× 23 782
Galina S. Zamay Russia 15 494 0.9× 304 1.3× 63 0.6× 54 0.7× 59 1.5× 33 716
Olga S. Kolovskaya Russia 14 464 0.9× 297 1.3× 60 0.6× 47 0.6× 60 1.5× 31 694
Yongcan Guo China 19 823 1.6× 418 1.8× 193 2.0× 57 0.7× 157 3.9× 42 1.1k
Nicholas J. Panaro United States 14 293 0.6× 554 2.4× 68 0.7× 93 1.1× 35 0.9× 18 944

Countries citing papers authored by Yuxuan Li

Since Specialization
Citations

This map shows the geographic impact of Yuxuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuxuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuxuan Li more than expected).

Fields of papers citing papers by Yuxuan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuxuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuxuan Li. The network helps show where Yuxuan Li may publish in the future.

Co-authorship network of co-authors of Yuxuan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yuxuan Li. A scholar is included among the top collaborators of Yuxuan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuxuan Li. Yuxuan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Yupeng, Yuxuan Li, Zhiyong Xiong, et al.. (2025). CircPIK3C3 inhibits hepatocellular carcinoma progression and lenvatinib resistance by suppressing the Wnt/β-catenin pathway via the miR-452-5p/SOX15 axis. Genomics. 117(2). 110999–110999. 4 indexed citations
2.
Li, Yuxuan, Xinchen Lv, Xu Liu, et al.. (2025). Computational design of a high-precision mitochondrial DNA cytosine base editor. Nature Structural & Molecular Biology. 32(12). 2575–2586.
3.
You, Kaiqiang, Yuxuan Li, Hui Yang, et al.. (2025). PhaSepDB 3.0: a comprehensive knowledgebase of phase separation-related proteins from AI-assisted curation. Nucleic Acids Research. 54(D1). D445–D450. 1 indexed citations
4.
Xing, Gaowa, et al.. (2025). Alginate-gelatin hydrogel scaffolds for establishing physiological barriers on a gut-brain-axis microchip. International Journal of Biological Macromolecules. 312. 144084–144084. 1 indexed citations
5.
Liu, Shaojun, et al.. (2024). N6-methyladenosine-dependent signaling in colorectal cancer: Functions and clinical potential. Critical Reviews in Oncology/Hematology. 198. 104360–104360. 3 indexed citations
6.
Liu, Xiliang, et al.. (2024). Unveiling synergies: Integrating TCM herbal medicine and acupuncture with conventional approaches in stroke management. Neuroscience. 567. 109–122. 4 indexed citations
7.
Li, Yuxuan, et al.. (2024). Mobilizing endogenous neuroprotection: the mechanism of the protective effect of acupuncture on the brain after stroke. Frontiers in Neuroscience. 18. 1181670–1181670. 5 indexed citations
8.
Chen, Shiyu, et al.. (2024). Establishment of microneurovascular units in alginate hydrogel microspheres to reveal the anti-hypoxic effect of salidroside. Journal of Pharmaceutical Analysis. 14(6). 100967–100967. 1 indexed citations
9.
Sun, Liang, Jiahui Wang, Yuxuan Li, et al.. (2024). Correlation of gasdermin B staining patterns with prognosis, progression, and immune response in colorectal cancer. BMC Cancer. 24(1). 567–567. 6 indexed citations
11.
Li, Mi, Ming Shi, Yuxuan Li, et al.. (2023). DddA homolog search and engineering expand sequence compatibility of mitochondrial base editing. Nature Communications. 14(1). 874–874. 38 indexed citations
12.
Ren, Yupeng, Yuxuan Li, Junfeng Deng, et al.. (2023). Lnc-ZEB2-19 Inhibits the Progression and Lenvatinib Resistance of Hepatocellular Carcinoma by Attenuating the NF-κB Signaling Pathway through the TRA2A/RSPH14 Axis. International Journal of Biological Sciences. 19(12). 3678–3693. 12 indexed citations
13.
Shang, Yuting, et al.. (2023). Multiplex bacteria detection using one-pot CRISPR/Cas13a-based droplet microfluidics. Biosensors and Bioelectronics. 243. 115771–115771. 56 indexed citations
14.
Li, Yuxuan, Sheng‐Jie Yue, Yifan Zheng, et al.. (2023). Economical Production of Phenazine-1-carboxylic Acid from Glycerol by Pseudomonas chlororaphis Using Cost-Effective Minimal Medium. Biology. 12(10). 1292–1292. 5 indexed citations
15.
Wu, Jianfeng, Fei Yao, Yuxuan Li, et al.. (2022). The cancer-testis antigen FBXO39 predicts poor prognosis and is associated with stemness and aggressiveness in glioma. Pathology - Research and Practice. 239. 154168–154168. 3 indexed citations
16.
Zeng, Ruijin, Hexiang Gong, Yanli Li, et al.. (2022). CRISPR-Cas12a-Derived Photoelectrochemical Biosensor for Point-Of-Care Diagnosis of Nucleic Acid. Analytical Chemistry. 94(20). 7442–7448. 326 indexed citations breakdown →
17.
Wu, Yundi, Qiuwan Li, Yang Liu, et al.. (2021). Targeting hypoxia for sensitization of tumors to apoptosis enhancement through supramolecular biohybrid bacteria. International Journal of Pharmaceutics. 605. 120817–120817. 15 indexed citations
18.
Wang, Yong, Xiaoxu Chen, Boyang Han, et al.. (2021). Expanding the Structural Diversity of Protein Building Blocks with Noncanonical Amino Acids Biosynthesized from Aromatic Thiols. Angewandte Chemie International Edition. 60(18). 10040–10048. 29 indexed citations
19.
Chen, Chao, Guiling Yu, Yujia Huang, et al.. (2021). Genetic-code-expanded cell-based therapy for treating diabetes in mice. Nature Chemical Biology. 18(1). 47–55. 38 indexed citations
20.
Jiang, Shenyi, Yuxuan Li, Lin Yuan, et al.. (2016). IL-35 Inhibits Angiogenesis through VEGF/Ang2/Tie2 Pathway in Rheumatoid Arthritis. Cellular Physiology and Biochemistry. 40(5). 1105–1116. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026